Bio-Rad Enables Laboratory Excellence in Immunohematology with Launch of IH-500 NEXT Fully Automated System for ID-Cards
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards.


